Archives of Internal Medicine · 1997 · 161 citations · 27 references
Veterinary MedicineImmunologyInternal MedicineImmunoregulationInflammationSepsisImmune-mediated DiseaseInterferon-based TherapySepsis ManagementSepsis PathophysiologyAnti-inflammatory ResponseHla Antigen ExpressionHla Expression LevelsImmunoregulatory SignalingInterferon-gamma ResponsesPretreatment
BACKGROUND: Immunoparalysis is defined as a decrease in the level of HLA-DR expression on monocytes during the course of sepsis. OBJECTIVE: To evaluate whether interferon gamma-1b has an immunoregulatory effect in patients with immunoparalysis during the compensatory anti-inflammatory response syndrome. METHODS: Of the patients admitted consecutively to the intensive care unit for the management of sepsis, 10 received interferon gamma-1b, 100 micrograms per 0.5 mL, after confirmation of HLA-DR expression of less than 30% on 2 consecutive days. The therapy was continued until HLA-DR expression remained more than 50% for 3 days. RESULTS: Interferon gamma-1b therapy resulted in the recovery of diminished levels of HLA-DR expression on monocytes. Of the 10 patients, 8 responded to treatment within 1 day. On the first day of interferon gamma-1b therapy, HLA-DR expression increased from mean (+/- SEM) pretreatment levels of 27% +/- 6% to 62% +/- 8% (P < .01) and remained high during the 28-day study period in 8 patients. The therapy was given to 2 patients a second time when HLA-DR expression on monocytes was less than 30%. The recovery of monocytic HLA-DR expression levels after administration of interferon gamma-1b was associated with restitution of monocytic function, reflected by a significant increase of plasma interleukin-6 (P < .05) and tumor necrosis factor alpha (P < .05) levels in 9 patients. CONCLUSIONS: This study shows that HLA-DR expression is a good marker of compensatory anti-inflammatory response syndrome. It also shows that interferon gamma-1b not only restored the levels of HLA-DR expression but also reestablished the ability of monocytes to secrete the cytokines interleukin-6 and tumor necrosis factor alpha.
27
Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia
Kevin J. Tracey, Yuman Fong, David Hesse et al. · Nature · 1987 · 2.5K citations
Sir Isaac Newton, sepsis, SIRS, and CARS
R C Bone · Critical Care Medicine · 1996 · 991 citations
Veterinary Medicine, Biomedical Sciences, Infectious Diseases +10
Charles J. Fisher · JAMA · 1994 · 932 citations